Prestige Consumer Healthcare Inc.

Ladies and gentlemen, thank you for standing by and welcome to the Q2 2021 Prestige Consumer Healthcare Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 on your telephone. Please be advised that today's conference is being recorded. If you require any further assistance, please press star 0. I would now like to hand the conference over to your host, Director of Investor Relations, Phil Terpolilli. Sir, please go ahead.

Thanks, Operator, and thank you to everyone who has joined us today. I'm going to call with me Ron Lombardi, our Chairman, President, and CEO, and Chris Sacco, our CFO. On today's call, we'll begin with some topical remarks given the pandemic, review the results of the second quarter and first half fiscal year 21, provide an outlook update, and then take questions from analysts. We have a slide presentation which accompanies today's call, can be accessed by visiting PrestigeConsumerHealthcare.com, clicking on the Investors link, and then on today's webcast and presentation. Remember, some of the information contained in the presentation today includes non-GAAP financial measures. Reconciliations between the nearest GAAP financial measures are included in today's earnings release and slide presentation. During today's call, management will also make forward-looking statements around risks and uncertainties, which are detailed in a complete safe harbor disclosure on page two of the slide presentation accompanying the call. These are important to review and contemplate. As everyone on the call today is well aware, business environment uncertainty remains heightened due to COVID-19. These items include Shutdown impacts for many areas of the economy, ongoing changes to consumer purchasing habits, the potential for a disrupted supply chain, heightened unemployment, and many other economic factors. This means that results could change at any time, and the forecasted impact of risk considerations is the best estimate based on the information available as of today's date. Additional information concerning risk factors and cautionary statements are available in our most recent SEC filings and most recent company 10-K. and I'll hand it over to our CEO, Ron Lombardi. Ron? Thanks, Phil.

Let's start on slide five. I'm pleased to report our long-term strategy and business positioning continue to deliver solid results as seen in Q2, where we experienced strong earnings growth and a stable revenue performance. We continue to focus on the critical near-term factors that I've previously discussed, in order to successfully navigate the pandemic environment. For starters, our long-term strategy of providing consumers with a wide range of brands they know and trust continues to work. In this unique time, we continue to see consumers turn to our leading brands to meet their healthcare needs. Meanwhile, our nimble business continuity efforts have been paying off. We continue to work closely with our manufacturing partners to ensure consistent service levels in this tight supply environment. In Q2, we continue to find effective ways to optimize our brands during the pandemic as consumer habits have begun to stabilize. We are benefiting from these agile investments in channels such as e-commerce, and our portfolio remains well positioned for the long term. Finally, Our strong operating model and disciplined capital strategy continue to reward stakeholders. We continue to use our industry-leading financial profile to further reduce debt in the quarter. We have reduced leverage levels to the lowest point since 2014, which continues to increase our capital allocation optionality. So to recap, we continue to feel good about our positioning and the agile adjustments made during COVID-19. Q2 performance reinforces the strength of our business and we look forward to further benefits. I'll now hand it over to Chris to review Q2 financial results.